Routinely analyzed leukocyte characteristics improve prediction of mortality after coronary angiography

Crystel M Gijsberts1, Guilielmus Hjm Ellenbroek2, Maarten J Ten Berg3

  • 1Experimental Cardiology Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands ICIN-Netherlands Heart Institute, the Netherlands.

Insights

Routine blood tests reveal leukocyte characteristics that significantly improve the prediction of mortality in patients with coronary artery disease (CAD). These findings enhance risk assessment for coronary angiography patients.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarkers

Background:

  • Inflammation and leukocyte infiltration are key features of atherosclerosis.
  • Standard hematology analyzers provide unutilized leukocyte data.
  • This data may correlate with coronary artery disease (CAD) severity and patient outcomes.

Purpose of the Study:

  • To investigate if routinely measured leukocyte characteristics predict CAD severity.
  • To assess if these characteristics improve mortality prediction in coronary angiography patients.

Main Methods:

  • 1015 patients undergoing coronary angiography were studied.
  • Leukocyte characteristics were analyzed using automated hematology analyzers.
  • Patients were followed for mortality and major adverse cardiovascular events (MACEs).

Main Results:

  • Monocyte percentage independently predicted all-cause mortality.
  • Monocyte-to-lymphocyte ratio best predicted cardiovascular mortality.
  • Leukocyte characteristics improved mortality risk prediction, but not for MACEs.

Conclusions:

  • Unreported leukocyte data from routine analyzers enhance mortality prediction in coronary angiography patients.
  • This offers a valuable, readily available tool for risk stratification.
  • Further research may integrate these markers into clinical practice.
Abstract